Shorts

Pearls & Perspectives: The Ideal Candidate for Focal Therapy

Pearls & Perspectives: The Ideal Candidate for Focal Therapy

a year ago

by

Amy M. Pearlman, MD

Trending on Urology Times

Adding darolutamide to ADT and radiation improves MFS in very high-risk localized prostate cancer

PROTEUS Substudy: Perioperative apalutamide plus ADT improves EFS vs surgery alone

Talazoparib/enzalutamide approved for HRR-mutated mAPMN/S prostate cancer

In situ immunotherapy shows encouraging survival findings in prostate cancer

Darolutamide associated with less cognitive change than enzalutamide in prostate cancer